Immunic, Inc. (IMUX) vs Nautilus Biotechnology, Inc. (NAUT)
Immunic, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Immunic, Inc. and Nautilus Biotechnology, Inc. are of similar size ($127.2M and $126.1M). Across the 9 metrics below, Nautilus Biotechnology, Inc. leads on 5 and Immunic, Inc. on 4.
Valuation
Profitability
| Metric | IMUX | NAUT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (138.17%) | (36.21%) | (57.72%) |
| Return on assets | (101.15%) | (30.00%) | (49.22%) |
| Return on invested capital | 0.00% | (83.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack